Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Equity (2021 - 2025)

Krystal Biotech (KRYS) has disclosed Return on Equity for 5 consecutive years, with 0.17% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 8.0% to 0.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17% through Dec 2025, up 8.0% year-over-year, with the annual reading at 0.19% for FY2025, 9.0% up from the prior year.
  • Return on Equity hit 0.17% in Q4 2025 for Krystal Biotech, down from 0.18% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.18% in Q3 2025 to a low of 0.27% in Q1 2023.
  • Historically, Return on Equity has averaged 0.03% across 5 years, with a median of 0.01% in 2023.
  • Biggest five-year swings in Return on Equity: decreased -12bps in 2022 and later surged 38bps in 2024.
  • Year by year, Return on Equity stood at 0.14% in 2021, then crashed by -90bps to 0.26% in 2022, then soared by 105bps to 0.01% in 2023, then skyrocketed by 583bps to 0.1% in 2024, then soared by 79bps to 0.17% in 2025.
  • Business Quant data shows Return on Equity for KRYS at 0.17% in Q4 2025, 0.18% in Q3 2025, and 0.14% in Q2 2025.